Proof of Therapeutical Effectiveness of Nootropic and Vasoactive Drugs

A. Principles of Controlled Clinical Studies.- Principles of Controlled Clinical Studies in Psychogeriatrics.- Prognosis of Cerebrovascular Disease.- B. Controlled Clinical Studies with Nicergoline in Chronic CVD.- Promoting Vigilance in Older People: Comparative Pharmaco-EEG and Psychometric Studies with Nicergoline by Oral and Intramuscular Administration.- Correlation Between Computerized EEG and Clinical Findings in Patients with Senile Dementia.- A Placebo-Controlled Study with Nicergoline in Patients with Organic Brain Syndrome, Suffering from Cochlear and Vestibular Disturbances.- C. Metabolism and Research of Neurotransmitters.- Neurotransmitter Alterations in the Aging Brain.- Neurochemical Effects of Ergoline Derivatives.- Pharmacological Intervention on Some Enzyme Activities of Various Brain Areas During Hypoxia and Post-Hypoxic Recovery.- The Effects of Nicergoline and Other Vaso-Active Substances on Molecular Biological Processes in the Brain and Their Effects on the Learning Abilities of Rats.- D. Results in Cardio-Vascular Research.- Salutary Actions of Nicergoline During Experimental Coronary Artery Occlusion and Reperfusion.- E. Haemorrheology/Haemostasiology.- A General Introduction of Haemorrheology and its Clinical Importance.- Effects of a Single I.V. Dose of Nicergoline on Haemorrheological and Haemodynamic Parameters in Peripheral Vascular Disease. A Double-Blind, Cross-Over Study.- The Effects of Nicergoline on the Filtrability of Hyperosmolar Blood.- Influence of Nicergoline on Platelet Aggregation and Erythrocyte Filterability.- F. Nicergoline in Otolaryngology and Ophthalmology.- Nicergoline Injectable in the Treatment of Cochlear Emergencies.- Long-Term Study with Nicergoline in Ophthalmological Practice.- G. Nicergoline in Patients with Transitory Ischaemic Attacks and in Post-Stroke Patients.- Transitory Ischaemic Attacks and Their Treatment with Nicergoline.- Methodological Approach to the Clinical Evaluation of Nootropic Drugs.- H.